This compound is a pharmaceutical reference impurity, specifically a derivative of afatinib, characterized by a quinazoline core with chlorofluoroaniline, oxolan-3-yloxy, and hydroxypyrrolidinone substituents. It is used primarily as a reference standard in quality control and analytical testing for afatinib-related pharmaceuticals.
İçerik kapsamı: Bu sayfadaki bilgiler kimyasal tanımlama ile endüstriyel tedarik, araştırma ve üretim bağlamlarına ilişkindir. Tedavi iddiası, tıbbi tavsiye veya ilaç kullanım talimatı niteliği taşımaz.
Bu bileşiği tedarik ediyor veya sağlıyor musunuz?
Envanterinizi listeleyin veya satın alma talebi gönderin
CAS 2223677-58-3
4-Amino-1-methyl-3-propyl-1H-pyrazole-5-carboxamide--hydrogen chloride (1/1)
pharmaceutical reference impurity
Adrenaline EP Impurity E HCl
pharmaceutical reference impurity
N1,N2-Bis(4-((3-chloro-4-fluorophenyl)amino)-7-(((S)-tetrahydrofuran-3-yl)oxy)quinazolin-6-yl)oxalamide
Pharmaceutical intermediate for Afatinib impurities
(S)-N1-(4-((3-CHLORO-4-FLUOROPHENYL)AMINO)-7-((TETRAHYDROFURAN-3-YL)OXY)QUINAZOLIN-6-YL)-N2,N2-DIMETHYLOXALAMIDE
pharmaceutical intermediate
(S)-4-Methyloxazolidine-2,5-dione
pharmaceutical intermediate
1-(4-chlorophenyl)-3-oxoisoindoline
Pharmaceutical intermediate synthesis
1-[4-(3-chloro-4-fluoroanilino)-7-[(3S)-oxolan-3-yl]oxyquinazolin-6-yl]-5-hydroxypyrrolidin-2-one
HIMWAPFLBWDJMH-SZQRVLIRSA-N
C1COC[C@H]1OC2=C(C=C3C(=C2)N=CN=C3NC4=CC(=C(C=C4)F)Cl)N5C(CCC5=O)O